Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis
Non-invasive biomarkers are necessary for diagnosis and monitoring disease activity in lupus nephritis (LN) to circumvent risks and limitations of renal biopsies. To identify new non-invasive cellular biomarkers in the urine sediment of LN patients, which may reflect kidney inflammation and can be u...
Main Authors: | Martina Bertolo, Sabine Baumgart, Pawel Durek, Anette Peddinghaus, Henrik Mei, Thomas Rose, Philipp Enghard, Andreas Grützkau |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00256/full |
Similar Items
-
Lupus nephritis : frontiers and challenges /
by: Sheashaa, Hussein A.
Published: (2010) -
Current and Emerging Therapy on Lupus Nephritis
by: Lucky Aziza Bawazier
Published: (2018-01-01) -
Tubulointerstitial lupus nephritis
by: Ala Ali, et al.
Published: (2013-01-01) -
Lupus Nephritis Biomarkers: A Critical Review
by: Fatima K. Alduraibi, et al.
Published: (2024-01-01) -
Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019-03-01)